FERRARA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 2.012
EU - Europa 1.603
AS - Asia 1.240
SA - Sud America 278
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.154
Nazione #
US - Stati Uniti d'America 1.962
SG - Singapore 535
UA - Ucraina 367
IE - Irlanda 302
SE - Svezia 284
BR - Brasile 237
CN - Cina 195
VN - Vietnam 189
RU - Federazione Russa 185
HK - Hong Kong 165
DE - Germania 111
FI - Finlandia 99
IT - Italia 98
KR - Corea 51
GB - Regno Unito 48
FR - Francia 30
CA - Canada 28
JP - Giappone 24
CH - Svizzera 17
TR - Turchia 17
AT - Austria 16
MX - Messico 16
AR - Argentina 14
ID - Indonesia 13
IN - India 12
EC - Ecuador 11
BE - Belgio 9
UZ - Uzbekistan 8
BD - Bangladesh 7
NL - Olanda 7
PL - Polonia 7
PY - Paraguay 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
KE - Kenya 4
CO - Colombia 3
ES - Italia 3
EU - Europa 3
GR - Grecia 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
SA - Arabia Saudita 3
VE - Venezuela 3
BI - Burundi 2
CL - Cile 2
HN - Honduras 2
KW - Kuwait 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PK - Pakistan 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
PE - Perù 1
RO - Romania 1
SO - Somalia 1
UY - Uruguay 1
Totale 5.154
Città #
Chandler 343
Singapore 304
Dublin 302
Hong Kong 164
Jacksonville 162
San Mateo 154
Boardman 118
Santa Clara 101
Medford 86
Princeton 86
Dong Ket 81
Ann Arbor 73
Beijing 64
Moscow 61
Des Moines 57
Wilmington 56
Ashburn 52
Seoul 51
Altamura 43
Lawrence 41
Perugia 38
Andover 37
Ho Chi Minh City 31
Hanoi 28
New York 24
Tokyo 24
Norwalk 21
Saint Petersburg 21
The Dalles 21
Woodbridge 20
Piscataway 19
Los Angeles 18
São Paulo 18
Munich 14
Edmonton 13
Falls Church 11
Izmir 11
Helsinki 10
Brussels 9
Shanghai 9
Dearborn 7
Guayaquil 7
Rio de Janeiro 7
Chennai 6
Haiphong 6
San Paolo di Civitate 6
Jakarta 5
Lausanne 5
Nuremberg 5
Porto Alegre 5
San Francisco 5
Stockholm 5
Turku 5
Ankara 4
Auburn Hills 4
Changsha 4
Chicago 4
Da Nang 4
Denver 4
Falkenstein 4
Guangzhou 4
Montreal 4
Nairobi 4
Phoenix 4
Toronto 4
Vienna 4
Amsterdam 3
Asunción 3
Belo Horizonte 3
Boston 3
Bromma 3
Brooklyn 3
Cambridge 3
Chisinau 3
Columbus 3
Dallas 3
Frankfurt Am Main 3
Guarulhos 3
Ha Long 3
Houston 3
London 3
Mexico City 3
Poplar 3
Quận Một 3
Salvador 3
San Diego 3
São José do Rio Preto 3
Três Lagoas 3
Uberlândia 3
Warsaw 3
Zhengzhou 3
Bandung 2
Barra Mansa 2
Brumadinho 2
Bình An 2
Campinas 2
Cape Town 2
Caracas 2
Carapicuíba 2
Cuiabá 2
Totale 3.015
Nome #
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. 141
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis? 110
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 109
Basi genetiche della predisposizione alla tubercolosi (TB) ed alle micobatteriosi non tubercolari. 108
Il trattamento della tubercolosi. 92
A method to quantify mycobacteria infection of cells from in vitro experiments 92
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. 92
[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers] 91
Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension 90
Combination fluticasone end salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children 87
Chronic empyema: importance of preventing complications in the management of pleural effusions 85
Long term Moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. 84
Clinical and operational value of the XDR-TB definition. 84
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test 84
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. 83
Cough mechanical assistance in neuromuscular patients with respiratory failure: a retrospective evaluation 82
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. 82
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 81
Trends and challenges in tuberculosis in a medium-sized southern European setting 80
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? 76
Combination fluticasone and salmeterol vs fixed dose combination budesonide and formoterol in adults and children 74
Sarcoidosi: patogenesi 74
Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. 73
Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. 71
Management of multidrug-resistant tuberculosis in Italy. 71
Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis. 68
Alveolar macrophages produce CCL18 during early phases infection by M. tuberculosis 68
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy 67
C’è esigenza di interventi mirati nei lavoratori stranieri affettida infezione tubercolare latente? Uno studio sulla compliancealla terapia antitubercolare in operatori sanitari 66
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 65
Corticosteroids for idiophatic pulmonary fibrosis. 64
Clinical use of levofloxacin in the long term treatment of drug resistant tuberculosis 64
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. 64
Xpert MTB/RIF test for tuberculosis. 62
Macrolides for chronic asthma. 60
Dossier Tubercolosi. La tubercolosi agli inizi del XXI secolo: diagnosi e terapia 60
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. 59
Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. 59
Epidemiology and clinical managment of XDR-TB: a systematic review. 58
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 58
Mycobacterium tuberculosis induces CCL18 in human macrophages. 58
Tuberculosis in prisons: anatomy of global neglect. 57
Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy 56
Micobatteriosi non tubercolari 55
Macrolides in the treatment of asthma and cystic fibrosis. 55
Screening of immigrants in the UK for latent tuberculosis. 55
Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. 55
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. 55
Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection. 54
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. 54
Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan 54
Macrolides for chronic asthma. 53
Il trattamento della Tubercolosi 53
High risk of tuberculosis in health care workers in Romania. 53
Differences among multidrug-resistant tuberculosis patients in two metropolitan areas 53
Validation of the tuberculin skin test cut-off in BCG vaccinated individuals using the QuantiFERON-TB Gold 53
Macrolides for chronic asthma 53
TB or not TB: update from the ERS Respiratory Infection Assembly 10. 53
New tools for a better diagnosis of latent tuberculosis infection 51
The best on infections: update from the 2010 ERS Congress. 50
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis 50
Blood tests for diagnosis of tuberculosis - Authors' reply. 48
T-Cell Therapy: Options for Infectious Diseases 48
Corticosteroids for IPF: a systematic review 47
Macrolides for chronic asthma. 45
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 45
I nuovi test per la diagnosi di infezione tubercolare. 45
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 44
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma 44
Isoniazid preventive treatment: predictors of adverse events and treatment completion. 43
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test 42
Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome 42
High risk of tuberculosis in health care workers in Romania 41
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000. 40
No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses. 40
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 40
Extensively drug-resistant tuberculosis, Italy and Germany. 39
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence 38
Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses? 38
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays 37
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: The case of two Nordic countries 37
Need for combined interventions and operational research to tackle tuberculous meningitis 35
Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry 34
Tuberculosis: Novel opportunities to control an old disease. 33
Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group 32
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays 27
Totale 5.272
Categoria #
all - tutte 25.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021376 0 0 0 0 0 52 45 1 88 34 62 94
2021/2022609 19 107 18 46 11 7 12 207 3 8 58 113
2022/20231.072 98 143 7 110 95 147 0 44 393 1 26 8
2023/2024362 21 57 22 10 4 3 59 3 68 5 53 57
2024/2025807 4 110 84 10 100 12 26 61 177 52 128 43
2025/20261.066 141 171 138 304 245 67 0 0 0 0 0 0
Totale 5.272